Microtubule Associated Protein 2 (MAP2) Antikörper

Antigen: Microtubule Associated Protein 2 (MAP2)

Synonyme: MAP2A, MAP2B, MAP2C, DKFZp686I2148, MAP2, MAP-2, Mtap-2, xmap2, MGC53131, a730034c02, map2, MGC145864

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human

Applikation: Immunhistochemie (IHC), Western Blot (WB)

Produktnummer: ABIN350438

Produktbeschreibung

Weitere Bezeichnung: MAP2 (Microtubule-associated protein 2, MAP-2, MAP 2, MAP2R)

Swiss-Prot: P11137

Immunogen: A synthetic peptide from human MAP2 (Microtubule-associated protein 2, MAP-2, MAP 2, MAP2R) conjugated to an immunogenic carrier protein was used as the immunogen.

Format: Lyophilized

Beschreibung: Regulates and organizes microtubules; may serve as a scaffolding protein for neuromodulatory activities. FUNCTION: The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. DEVELOPMENTAL STAGE: Isoform MAP2C is expressed during embryonic brain development and until postanatal day 10. Isoform MAP2B is expressed throughout brain development. Also known as: Microtubule-associated protein 2, MAP 2, MAP-2, MAP2R.

Spezifität: Appears to be specific for MAP-2.

Anwendungen

Applikationshinweise: IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.

Reinheit: whole serum

Lagerung: Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Kosik, Orecchio, Bakalis et al.: "Partial sequence of MAP2 in the region of a shared epitope with Alzheimer neurofibrillary tangles." in: Journal of neurochemistry, Vol. 51, Issue 2, pp. 587-98, 1988 (PubMed).

Dammerman, Yen, Shafit-Zagardo: "Sequence of a human MAP-2 region sharing epitopes with Alzheimer neurofibrillary tangles." in: Journal of neuroscience research, Vol. 24, Issue 4, pp. 487-95, 1990 (PubMed).

Albala, Kalcheva, Shafit-Zagardo: "Characterization of the transcripts encoding two isoforms of human microtubule-associated protein-2 (MAP-2)." in: Gene, Vol. 136, Issue 1-2, pp. 377-8, 1994 (PubMed).

DeGiorgis, Jaffe, Moreira et al.: "Phosphoproteomic analysis of synaptosomes from human cerebral cortex." in: Journal of proteome research, Vol. 4, Issue 2, pp. 306-15, 2005 (PubMed).

Sjoeblom, Jones, Wood et al.: "The consensus coding sequences of human breast and colorectal cancers." in: Science (New York, N.Y.), Vol. 314, Issue 5797, pp. 268-74, 2006 (PubMed).

Olsen, Blagoev, Gnad et al.: "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." in: Cell, Vol. 127, Issue 3, pp. 635-48, 2006 (PubMed).

Matsuoka, Ballif, Smogorzewska et al.: "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." in: Science (New York, N.Y.), Vol. 316, Issue 5828, pp. 1160-6, 2007 (PubMed).

Cantin, Yi, Lu et al.: "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." in: Journal of proteome research, Vol. 7, Issue 3, pp. 1346-51, 2008 (PubMed).